In this article
The Trump administration and AstraZeneca
have reached an agreement for the U.K.-based pharmaceutical giant to cut drug prices in the U.S., MSNBC reported Friday.
The deal with AstraZeneca would follow a similar pact with U.S. drugmaker Pfizer
, which was announced late last month.







